Why unlimited access unlocks opportunities

By Dr Neil Taylor

When it comes to enterprise software pricing, the debate between site licenses and per-seat licenses r...

Why protein structure databases remain critical infrastructure for AI-driven drug discovery

By Dr. Neil Taylor

As AI capabilities expand at breakneck speed, a prov...

Balancing the promise of targeted protein degradation with organisational readiness and infrastructure reality

Like many professionals in the drug dis...